US Patent Issued to ANTECIP BIOVENTURES II on May 27 for "Bupropion dosage forms with reduced food and alcohol dosing effects" (New York Inventor)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,961, issued on May 27, was assigned to ANTECIP BIOVENTURES II LLC (New York).

"Bupropion dosage forms with reduced food and alcohol dosing effects" was invented by Herriot Tabuteau (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to dosage forms comprising bupropion hydrochloride, another salt form of bupropion, or the free base form of bupropion; dextromethorphan hydrobromide, another salt form of dextromethorphan, or the free base form of dextromethorphan, and a polymer. In some embodiments, the dosage form has no significant dose dumping of bupropion in the presence of ethanol in vitro. In some embodiments, the dos...